Vera Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -53.41M-32.61M-89.06M-95.99M-152.15M
Share-based Compensation 0.33M3.01M8.89M11.49M20.80M
Gains from Investment Securities 0.13M0.20M5.80M46.80M
Cash from Restructuring 2.42M1.00M
Cash from Operations -34.81M-23.71M-67.60M-92.18M-134.68M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 2.27M2.22M2.06M
Amortization of Deferred Charges 0.13M
Depreciation & Amortization (CF) 0.25M0.18M-0.85M0.02M0.10M
Change in Working Capital
Change in Account Payables 0.57M0.47M10.61M-0.87M-3.45M
Change in Accured Expenses -0.48M5.39M7.04M-2.21M7.19M
Other Working Capital Changes 0.14M2.31M8.18M-2.65M-2.41M
Investing Activities
Capital Expenditures 0.10M5.00M0.06M0.06M0.97M
Sales of Property, Plant and Equipment 0.06M
Divestments 0.80M
Change in Acquisitions & Divestments 78.00M176.02M274.96M
Cash from Investing Activities -0.04M-4.20M-70.55M-39.43M-425.03M
Financing Activities
Other financing activities 0.02M2.77M
Cash from Financing Activities 85.29M53.88M101.93M133.54M606.67M
Additional items
Change in Cash 50.44M25.97M-36.22M1.93M46.97M
Free Cash Flow -34.91M-28.71M-67.66M-92.24M-135.65M
Net Cash Flow 50.44M25.97M-36.22M1.93M46.97M